These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 31857035)

  • 21. Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation.
    Kumar S; Barbhaiya C; Nagashima K; Choi EK; Epstein LM; John RM; Maytin M; Albert CM; Miller AL; Koplan BA; Michaud GF; Tedrow UB; Stevenson WG
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):87-93. PubMed ID: 25527825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy Without Background Implantable Cardioverter Defibrillator Therapy: A Multicenter International Ventricular Tachycardia Registry.
    Santangeli P; Tung R; Xue Y; Chung FP; Lin YJ; Di Biase L; Zhan X; Lin CY; Wei W; Mohanty S; Burkhardt DJ; Zado ES; Callans DJ; Marchlinski FE; Wu S; Chen SA; Natale A
    JACC Clin Electrophysiol; 2019 Jan; 5(1):55-65. PubMed ID: 30678787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study.
    Carbucicchio C; Santamaria M; Trevisi N; Maccabelli G; Giraldi F; Fassini G; Riva S; Moltrasio M; Cireddu M; Veglia F; Della Bella P
    Circulation; 2008 Jan; 117(4):462-9. PubMed ID: 18172038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a novel high-resolution mapping system for catheter ablation of ventricular arrhythmias.
    Viswanathan K; Mantziari L; Butcher C; Hodkinson E; Lim E; Khan H; Panikker S; Haldar S; Jarman JW; Jones DG; Hussain W; Foran JP; Markides V; Wong T
    Heart Rhythm; 2017 Feb; 14(2):176-183. PubMed ID: 27867071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of Catheter Ablation of Ventricular Tachycardia in the Setting of Structural Heart Disease.
    Betensky BP; Marchlinski FE
    Curr Cardiol Rep; 2016 Jul; 18(7):68. PubMed ID: 27234813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Procedural and clinical outcomes after catheter ablation of unstable ventricular tachycardia supported by a percutaneous left ventricular assist device.
    Aryana A; Gearoid O'Neill P; Gregory D; Scotti D; Bailey S; Brunton S; Chang M; d'Avila A
    Heart Rhythm; 2014 Jul; 11(7):1122-30. PubMed ID: 24732372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiofrequency catheter ablation of idiopathic ventricular arrhythmias originating from intramural foci in the left ventricular outflow tract: efficacy of sequential versus simultaneous unipolar catheter ablation.
    Yamada T; Maddox WR; McElderry HT; Doppalapudi H; Plumb VJ; Kay GN
    Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):344-52. PubMed ID: 25637597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of percutaneous left ventricular assist devices during ventricular tachycardia ablation.
    Bunch TJ; Mahapatra S; Madhu Reddy Y; Lakkireddy D
    Europace; 2012 Aug; 14 Suppl 2():ii26-ii32. PubMed ID: 22832915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of Ventricular Tachycardia Induction and Mapping for Patients Referred for Epicardial Ablation.
    Nazer B; Woods C; Dewland T; Moyers B; Badhwar N; Gerstenfeld EP
    Pacing Clin Electrophysiol; 2015 Nov; 38(11):1333-42. PubMed ID: 26228002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catheter ablation for ventricular tachycardia (VT) in patients with ischemic heart disease: a systematic review and a meta-analysis of randomized controlled trials.
    Patel D; Hasselblad V; Jackson KP; Pokorney SD; Daubert JP; Al-Khatib SM
    J Interv Card Electrophysiol; 2016 Mar; 45(2):111-7. PubMed ID: 26695501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catheter Ablation of Ischemic Ventricular Tachycardia With Remote Magnetic Navigation: STOP-VT Multicenter Trial.
    Skoda J; Arya A; Garcia F; Gerstenfeld E; Marchlinski F; Hindricks G; Miller J; Petru J; Sediva L; Sha Q; Janotka M; Chovanec M; Waldauf P; Neuzil P; Reddy VY
    J Cardiovasc Electrophysiol; 2016 Mar; 27 Suppl 1():S29-37. PubMed ID: 26969220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catheter ablation of subepicardial ventricular tachycardia using electroanatomic mapping.
    Ouyang F; Bänsch D; Schaumann A; Ernst S; Linder C; Falk P; Hachiya H; Kuck KH; Antz M
    Herz; 2003 Nov; 28(7):591-7. PubMed ID: 14689119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical impact of mapping strategies for treatment of ventricular tachycardias in patients with structural heart disease.
    Makimoto H; Nakajima I; Miyamoto K; Yamada Y; Okamura H; Noda T; Aiba T; Kamakura S; Kusano K; Shimizu W; Satomi K
    Pacing Clin Electrophysiol; 2015 May; 38(5):630-40. PubMed ID: 25639823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substrate mapping vs. tachycardia mapping using CARTO in patients with coronary artery disease and ventricular tachycardia: impact on outcome of catheter ablation.
    Volkmer M; Ouyang F; Deger F; Ernst S; Goya M; Bänsch D; Berodt K; Kuck KH; Antz M
    Europace; 2006 Nov; 8(11):968-76. PubMed ID: 17043071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcomes of combined epicardial and endocardial ablation of monomorphic ventricular tachycardia related to hypertrophic cardiomyopathy.
    Dukkipati SR; d'Avila A; Soejima K; Bala R; Inada K; Singh S; Stevenson WG; Marchlinski FE; Reddy VY
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):185-94. PubMed ID: 21270104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electroanatomic mapping of the endocardium. Implication for catheter ablation of ventricular tachycardia.
    Wetzel U; Hindricks G; Dorszewski A; Schirdewahn P; Gerds-Li JH; Piorkowski C; Kobza R; Tanner H; Kottkamp H
    Herz; 2003 Nov; 28(7):583-90. PubMed ID: 14689118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry.
    Jefic D; Joel B; Good E; Morady F; Rosman H; Knight B; Bogun F
    Heart Rhythm; 2009 Feb; 6(2):189-95. PubMed ID: 19187909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catheter ablation of ventricular tachycardia: Lessons learned from past clinical trials and implications for future clinical trials.
    Pokorney SD; Friedman DJ; Calkins H; Callans DJ; Daoud EG; Della-Bella P; Jackson KP; Shivkumar K; Saba S; Sapp J; Stevenson WG; Al-Khatib SM
    Heart Rhythm; 2016 Aug; 13(8):1748-54. PubMed ID: 27050910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mapping and ablation procedures for the treatment of ventricular tachycardia.
    Killu AM; Mulpuru SK; Asirvatham SJ
    Expert Rev Cardiovasc Ther; 2016 Sep; 14(9):1071-87. PubMed ID: 27269734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiofrequency Catheter Ablation of Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy and Apical Aneurysm.
    Igarashi M; Nogami A; Kurosaki K; Hanaki Y; Komatsu Y; Fukamizu S; Morishima I; Kaitani K; Nishiuchi S; Talib AK; Machino T; Kuroki K; Yamasaki H; Murakoshi N; Sekiguchi Y; Kuga K; Aonuma K
    JACC Clin Electrophysiol; 2018 Mar; 4(3):339-350. PubMed ID: 30089559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.